Polymyositis

Type: Keyphrase

Name: Polymyositis

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Questcor Pharmaceuticals Q1 net income up

Questcor Pharmaceuticals, Inc., a biopharmaceutical company, has reported that net income for the first quarter ended March 31, 2013 was $39.06 million, or $0.65 per diluted share, compared to $38.54 million, or $0.58 per diluted share, for the same quarter ... [Published Individual.com - May 10 2013]

Entities: Questcor Pharmaceuticals Incorporated, Don M Bailey, Polymyositis, Acthar

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

/PRNewswire/ --$ Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas on May 14, 2013 at 4:20 PM PT / 7:20 PM ET .A live webcast ... [Published Barchart - May 08 2013]

Entities: Questcor Pharmaceuticals Incorporated, Healthcare Conference, Nephrotic Syndrome, Bank of America Merrill Lynch, Acthar

First reported Apr 30 2013 - Updated May 01 2013 - 3 reports

Questcor Misses Q1 Estimates (QCOR)

Questcor Pharmaceuticals Inc.’s (NASDAQ: QCOR) fiscal first-quarter results disappointed the street. The pharmaceutical company reported first quarter results, late last evening, which showed both revenue and adjusted earnings falling short of consensus ... [Published Quote.com India - May 01 2013]

Entities: Acthar, Ampoule, Polymyositis

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Questcor Pharmaceuticals Earnings:Here’s Why the Stock is Falling Now

Questcor Pharmaceuticals, Inc. ( NASDAQ:QCOR ) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. ... [Published Wall St. Cheat Sheet - Apr 30 2013]

Entities: Questcor Pharmaceuticals Incorporated, Don M Bailey, Polymyositis, Acthar

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

Health Article - Muscle Atrophy: Causes, Symptoms & Diagnosis

amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease), which affects nerve cells that control voluntary muscle movementdermatomyositis (a muscle disease)Guillain-Barre syndrome (an autoimmune disease that leads to nerve inflammation ... [Published AARP - Segunda Juventud - Apr 19 2013]

Entities: autoimmune disease, Amyotrophic Lateral Sclerosis, Genetic Disorder, Multiple Sclerosis

First reported Apr 15 2013 - Updated Apr 15 2013 - 2 reports

QUESTCOR PHARMACEUTICALS INC: Questcor to Report First Quarter Results on April 30, 2013

/PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release first quarter 2013 financial results on Tuesday, April 30, 2013 after the close of the U.S. financial markets. The Company will host a conference call and ... [Published 4 Traders - Apr 15 2013]

Entities: Questcor Pharmaceuticals Incorporated, Nephrotic Syndrome, Acthar

Quotes

"Our first quarter results were below our expectations," said Don M Bailey, President and CEO of Questcor. "However, vial shipment activity and prescription levels in MS and rheumatology in late March and throughout April appear to indicate that positive sales momentum has returned. In particular, we note that our newest initiative related to the promotion of Acthar for dematomyositis and polymyositis is off to a strong start."

Questcor Gets a Bid After Q1 2013, Volatility Spikes [Published BioMedReports - May 16 2013]

...With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus." Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional...

Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference [Published Barchart - May 08 2013]

"Our first quarter results were below our expectations. However, vial shipment activity and prescription levels in MS and rheumatology in late March and throughout April appear to indicate that positive sales momentum has returned" President and CEO Don Bailey said in a statement

Questcor Pharma First Quarter Results Miss Estimates [Published RTTNews.com - May 01 2013]

Mr. Bailey continued, "In the first quarter, we made several operational changes aimed at ensuring and improving the delivery of Acthar for patients who rely on this important drug. We continue to seek to improve our business operations in order to benefit both Acthar patients and our shareholders by establishing a solid foundation for potential additional growth."

Questcor Pharmacueticals (QCOR) Misses Q1 EPS by 20c, Sales Well Short [Published Street Insider - Apr 30 2013]

More Content

sort by: Date \| Relevance
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - May 19 2013]
Questcor Gets a Bid After Q1 2013, Volatility S... [Published BioMedReports - May 16 2013]
Questcor Pharmaceuticals' CEO Presents at Bank ... [Published Seeking Alpha - May 15 2013]
Questcor Pharmaceuticals Q1 net income up [Published Individual.com - May 10 2013]
Questcor Pharmaceuticals to Present at Bank of ... [Published Barchart - May 08 2013]
Questcor Misses Q1 Estimates (QCOR) [Published Quote.com India - May 01 2013]
Questcor Pharma First Quarter Results Miss Esti... [Published RTTNews.com - May 01 2013]
Questcor Pharmaceuticals Earnings:Here’s Why th... [Published Wall St. Cheat Sheet - Apr 30 2013]
Questcor Pharmaceuticals Earnings:Here’s Why th... [Published Wall St. Cheat Sheet - Apr 30 2013]
Questcor Pharmacueticals (QCOR) Misses Q1 EPS b... [Published Street Insider - Apr 30 2013]
Questcor Reports First Quarter Financial Results [Published State Journal - Apr 30 2013]
Questcor Pharmaceuticals In Play Ahead of Earni... [Published BioMedReports - Apr 29 2013]
Champion won't quit in the fight of his life [Published Southwest Florida Herald Tribune - Apr 21 2013]
The Burly Man Will be Featured at Spawn Booth #... [Published PR.com Press Releases - Apr 20 2013]
Health Article - Muscle Atrophy: Causes, Sympto... [Published AARP - Segunda Juventud - Apr 19 2013]
QUESTCOR PHARMACEUTICALS INC: Questcor to Repor... [Published 4 Traders - Apr 15 2013]
Questcor to Report First Quarter Results on Apr... [Published KPTM FOX 42 - Apr 15 2013]
Zachary E. Lewis a.k.a the Burly Man Releases H... [Published PR.com Press Releases - Apr 06 2013]
Analgesic methods and compositions [Published PharmCast - Jan 03 2013]
Anti-inflammatory antibodies and uses therefor [Published PharmCast - Dec 19 2012]
Questcor and The Myositis Association Team Up T... [Published PR Newswire - Sep 13 2012]
Conjoint therapy for treating fibrotic diseases [Published PharmCast - Sep 04 2012]